• A 3-year-old child with multiple superficial erosions and yellowish crusts on the scalp and seborrheic areas
• A Case of an Autoimmune Blistering Disease: Pemphigus Vulgaris
• A Case of Refractory Pemphigus Herpetiformis with Positive Anti-Desmoglein 1 Antibody: Case Report and Literature Review to Revisit the Disease Characteristics of 167 Cases
• A Case Report on Senear-Usher Syndrome
• A Critical Appraisal of Gluten in Skin Disorders, the Evidence So Far, and Updated Recommendations
• A retrospective analysis of patient-reported physical and psychological stressors as trigger factors in autoimmune bullous disease
• Acantholytic Dyskeratoses of the Vulva: Clinicopathologic Characterization of 16 Cases and Review of the Literature
• Activity of apremilast in a patient with severe pemphigus vulgaris: case report
• Alteration of reactive oxygen species master transcription factor Nrf2 in keratinocytes exposed to monoclonal pathogenic antibody AK23 against desmoglein-3 in pemphigus vulgaris
• Atypical Presentation of Pemphigus Vulgaris with Co-Existing Carcinoma Lung and Acute Onset Internal Jugular Vein Thrombosis
• Autoimmune Dermatopathies of Horses
• Biomarkers in Pemphigus Vulgaris: A Systematic Review
• Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents
• Case series of cutaneous myiasis in neglected cases of autoimmune bullous disorders
• CD4+ T-cell Subsets and Cytokine Signature in Pemphigus Foliaceus Clinical Stratification beyond the th1/Th2 Paradigm
• Clinical management of bullous pemphigoid-The importance of cytology in diagnosis
• Clinical relevance of circulating autoantigen-specific T follicular regulatory cells in pemphigus vulgaris
• Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn's disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy
• Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus
• Comparison of selected cytomorphological features of canine pemphigus foliaceus and superficial pyoderma
• Comparison of the Clinical Efficacy of Rituximab Infusion and Dexamethasone-Cyclophosphamide Pulse Therapy and Their Effect on Serum Th1, Th2, and Th17 Cytokines in Pemphigus Vulgaris-A Prospective, Nonrandomized, Comparative Pilot Study
• Construction and validation of an audio-visual tool to instruct caregivers of patients with pemphigus in photographing skin and oral cavity lesions during tele-consultation: A cross-sectional study
• Correlation between serum cardiac troponin I level and PDAI score in patients with pemphigus vulgaris
• Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
• Decreased serum IL-38 levels in pemphigus vulgaris
• Diagnosis, treatment, and long-term outcomes of pediatric pemphigus: a retrospective study at tertiary medical centers
• Diagnostic Utility of Immunofluorescence on Formalin-Fixed Paraffin-Embedded Skin Biopsy
• Diagnostic yield of direct immunofluorescence testing in esophageal biopsies: A retrospective single-center cohort study of 99 consecutive cases
• Direct immunofluorescence on plucked hair outer root sheath can predict relapse in pemphigus vulgaris
• Direct Immunofluorescence Testing for Skin and Mucosal Ulcerations: A Retrospective Cohort Study of 352 Specimens
• Distorted frequency and functionality of natural killer cells in pemphigus vulgaris: A potential therapeutic target
• Epidemiological Insights into Autoimmune Bullous Diseases in China: A Comprehensive Analysis
• Establishing Minimal Clinically Important Differences (MCIDs) for the Pemphigus Disease Area Index (PDAI)
• Evaluation of combination therapy with ofatumumab and systemic corticosteroids for pemphigus: A multi-centre cohort study
• Exploring the role of vitamin D-VDR pathway in pemphigus foliaceous: a novel perspective on disease pathogenesis
• Factors associated with long-term complete remission in pemphigus patients receiving rituximab therapy
• Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus
• Generalized Hailey-Hailey disease associated with c.2395C>T ATP2C1 gene mutation and fatal outcome
• Gut Microbiome Dysbiosis in Patients with Pemphigus and Correlation with Pathogenic Autoantibodies
• Hailey-Hailey disease: A case report
• High serum total IgE levels correlate with urticarial lesions and IgE deposition in perilesional skin of bullous pemphigoid patients: An observational study
• Hypogammaglobulinemia-induced skin infections as a factor of post rituximab paradoxical flare in pemphigus
• Immunohistopathological analyses of a case of pemphigus vegetans with antibodies against desmoglein 1 and desmocollins 1-3
• Immunostimulatory effects of Toll-like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris
• Improvement in quality of life in patients with Hailey-Hailey disease treated with ablative CO₂ laser
• Koebnerization in Pemphigus Foliaceous following Total Knee Replacement - A Rare Entity
• Late-onset Hailey-Hailey disease with a novel ATP2C1 mutation in an older female patient
• Late-onset Morbus Hailey-Hailey
• Late-Term Outcomes of Surgical Treatment of Infective Endocarditis
• Localized pemphigus vulgaris on scalp: an atypical presentation
• Management of pain in the inpatient and non-surgical outpatient dermatology settings: A narrative review
• My mouth is on fire: a patient perspective on oral pemphigus vulgaris
• Nail changes in pemphigus: a systematic review and meta-analysis
• Oral Lesions of Immune-Mediated and Autoimmune Diseases: A 12-year Experience at a Single Brazilian Referral Center
• Paraneoplastic pemphigus presenting as a prodrome to aggressive T cell lymphoma
• Paraneoplastic pemphigus with airway involvement
• Pemphigus foliaceous accompanied by new erythema annulare centrifugum like lesions
• Pemphigus Foliaceous: A patient's perspective
• Pemphigus foliaceus successfully treated with upadacitinib
• Pemphigus following herpes simplex infection: A global comprehensive cohort study
• Pemphigus oral lesions area index (POLAI): A new scoring scale for assessing oral pemphigus vulgaris
• Pemphigus vegetans with autoantibodies against desmocollin and BP180
• Pemphigus vulgaris and mucous membrane pemphigoid: A systematic review of clinical manifestations, diagnosis, and treatment
• Pemphigus vulgaris in association with human immunodeficiency virus infection: A management dilemma
• Pemphigus Vulgaris Treated With Ibrutinib: A Case Report
• Pemphigus vulgaris: A rare diagnosis in a paediatric ward
• Pemphigus vulgaris: A rare diagnosis in a paediatric ward
• Pemphigus-Associated Desmoglein-Specific IgG1 and IgG4 Have a Dominant Agalactosylated Glycan Modification
• Pitfalls in gynecological cytology - review of the common and less frequent entities in Pap test
• Pitfalls in Gynecological Cytology: Review of the Common and Less Frequent Entities in Pap Test
• Possible therapeutic target MKK3 in blister formation in pemphigus
• Potential impact of gut microbiota on pemphigus: a two-sample Mendelian randomization study
• Prevalence of tobacco use in patients with autoimmune blistering diseases: A nationwide, cross-sectional study
• Psychosocial burden of autoimmune blistering diseases: A comprehensive survey study
• Pulmonary interstitial lesions in pemphigus mouse model: Verifying pemphigus may not be only limited to skin and mucosa
• Radiotherapy-induced pemphigus foliaceus successfully treated with rituximab
• Rapid desensitization in a patient with pemphigus vulgaris and rituximab-induced anaphylaxis
• Re-evaluating the prevalence of anti-desmocollin-1 IgA autoantibodies in canine pemphigus foliaceus
• Revisiting serum storage protocols: assessing the impact of temperature variations on indirect immunofluorescence testing for pemphigus and bullous pemphigoid
• Rituximab in the treatment of severe childhood pemphigus vulgaris accompanying phenylketonuria: A case report
• Rituximab-induced serum sickness in immunobullous disorders: A case series
• Seborrheic Pemphigus: A Misunderstood Variant of Pemphigus Foliaceus
• Secondary skin infection as trigger for post-rituximab paradoxical pemphigus flare?
• Serum interleukin-6 concentration in patients with pemphigus
• Severe aggravation and possible triggering of pemphigus vulgaris following COVID-19 vaccination: report of two cases
• Solitary verrucous plaque on a leg
• Spotlighting Emerging Therapies for Benign Familial Pemphigus
• Standardized Production of Anti-Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research
• State-of-the-art diagnosis of autoimmune blistering diseases
• Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation
• Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
• The emergence of circulating activated autoreactive Dsg3-specific Tfr cells is associated with long-term efficacy of RTX in PV patients
• The impact of lipidome on five inflammatory skin diseases: a Mendelian randomization study
• The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease
• The Skin and Lewy Body Disease
• Therapy of pemphigus foliaceous with prominent neutrophilic pustules with Acitretin: A case report and literature review
• Unmet Needs in Darier's Disease from a Patient's Perspective: Lessons Learnt from the German Registry
• Unraveling the role of the vitamin D-VDR pathway in pemphigus vulgaris from Tunisian patients
• Use of low-dose rituximab to treat pemphigus
• Utility of C4d Immunohistochemistry in the Diagnosis of Esophageal Pemphigus Vulgaris